Veterinary Technologies Corporation

Veterinary Technologies Corporation, commonly branded as VetTech, is a private animal-health biotechnology company focused on veterinary vaccines, diagnostics, and biowaste handling. The company was founded in 1993 and has emphasized products and services addressing infectious-disease and public-health needs in animals, with some applications relevant to human health. Its best-documented commercial product is RB51, a Brucella abortus vaccine for cattle used for brucellosis control, for which VetTech states it holds exclusive licensing rights from Virginia Tech and trademark rights in selected international markets. VetTech also provides consulting services and workshops in biotechnology, microbiology, and immunology, and appears to operate with a small, specialized leadership team tied to Virginia Tech veterinary researchers.